Spirox

About:

Spirox is a medical device company improving the quality of life for patients suffering from nasal obstruction.

Website: http://www.spiroxmed.com/#top

Top Investors: Kohlberg Kravis Roberts, Correlation Ventures, HealthQuest Capital, Western Technology Investment, Aisling Capital

Description:

Spirox is a California-based medical device company improving the quality of life for patients suffering from nasal obstruction. They are formerly known as Nasoform. Their first product, the LATERA absorbable nasal implant is designed to address one of the most common, yet undertreated, causes of nasal obstruction today, nasal valve collapse (NVC). The company intends to use the funds to complete development, seek US marketing authorization, and initiate product commercialization. Spirox was founded in 2011 and is headquartered in Menlo Park, California.

Total Funding Amount:

$71.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2011-01-01

Founders:

Donald Gonzales, Duke Rohlen

Number of Employees:

11-50

Last Funding Date:

2016-03-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai